36 Medidata Solutions Testimonials

“We have a strong partnership that goes way beyond a service provider relationship and enables us to drive high-quality analysis that would otherwise not be possible.”

“Visibility into patient reporting helps us mitigate protocol compliance issues early in the study rather than later, when it’s harder.”

"Adopting Medidata's machine-learning capabilities for centralized monitoring will not only put us in line with the updated ICH E6 R2 guidelines, but will also allow us to view clinical information at a more holistic level, better prioritize trial resources, and maintain data quality and integrity."

“Medidata is a valued and trusted partner. We use a range of their solutions which have allowed us to manage various unique and complex study requirements without having to use custom programming. This has ensured consistent and efficient trial execution.”

"We eliminated double data entry at the medical institution and were able to improve efficiency in clinical trial data capture."

"The Medidata products are very innovative and support our very complex oncology studies."

“One of the things that attracted me to Medidata was their ability to have a support mechanism [beyond] internal experts. Having a broad reach across the globe and supporting end users with devices are important. These factors attracted me to the Medidata DCT Program because not all competitors have that reach with their help desk and device support. It’s nice to have a reputable organization that allows us to lean on."

"Edge Payments stood out as a true end-to-end solution, and for its ability to reimburse sites quickly and accurately by directly integrating with Rave EDC– important as we invest in processes and technology that help us continue to stand out as a top-ranked performer for service and customer loyalty.”

“By using a system - that both the pharmaceutical industry recognizes, and the regulators accept - to execute high quality clinical trials, our mission to bring better treatments to patients faster can, ultimately, be realized.”

"Since Medidata developed the web services on the open operational data model (ODM) standard, Spaulding can rapidly apply integration designs to other studies and sponsors."

"Major corporations such as pharmaceutical and medical device manufacturers and institutions such as hospitals and nursing facilities have also committed fraud, sometimes on a grand scale. OIG has a strong record of investigating these corporate and institutional frauds, which often involve complex billing frauds, kickbacks, accounting schemes, illegal marketing and physician self-referral arrangements."

"We didn’t go shopping, we knew we wanted to use Medidata and it was a matter of working to find the right study build model to fit our business needs.”

“The team of Professional Services that I work with is very intelligent and collaborative We enjoy working with Medidata, it’s a great team. They’re always willing to come to the table and discuss our needs.”

“Medidata is a global brand that everyone knows, and everyone is happy to use. The seamless experience … creates a much easier experience for us. Sites are entering data very quickly. They know the system and they know these modules back and forth. They don’t have a lot of questions. And there’s a lot of confidence in that.”

“It is to everyone’s advantage to [use Medidata’s] unified platform so that there is one login. There is one way that people are accessing all the things they need to do with their data. If we’re thinking of patients and sites first, we have to think about that value…[so] they’re not worried about having multiple laptops and multiple logins.”